S.D. Rao, Epidemiology of parathyroid disorders. Best. Pr. Res Clin. Endocrinol. Metab. 32(6), 773–780 (2018)

Article  Google Scholar 

M.L. Griebeler et al. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965–2010). Bone 73, 1–7 (2015)

PubMed  Article  Google Scholar 

R.A. Wermers et al. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann. Intern. Med. 126(6), 433–440 (1997)

CAS  PubMed  Article  Google Scholar 

A. Abood, P. Vestergaard, Increasing incidence of primary hyperparathyroidism in Denmark. Dan. Med. J. 60(2), A4567 (2013)

PubMed  Google Scholar 

M. Nilsson et al. Mortality after surgery for primary hyperparathyroidism: Results from a nationwide cohort. Br. J. Surg. 108(7), 858–863 (2021)

CAS  PubMed  Article  Google Scholar 

S. Norenstedt et al. Postoperative mortality in parathyroid surgery in Sweden during five decades: Improved outcome despite older patients. Eur. J. Endocrinol. 160(2), 295–299 (2009)

CAS  PubMed  Article  Google Scholar 

P. Vestergaard et al. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J. Surg. 27(2), 216–222 (2003)

PubMed  Article  Google Scholar 

G. Hedbäck, A. Odén, Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery. Eur. J. Clin. Invest. 25(1), 48–52 (1995)

PubMed  Article  Google Scholar 

T. Dhondup et al. Risk of ESRD and mortality in kidney and bladder stone formers. Am. J. Kidney Dis. 72(6), 790–797 (2018)

PubMed  PubMed Central  Article  Google Scholar 

S.A. Everson-Rose, J.S. House, R.P. Mero, Depressive symptoms and mortality risk in a national sample: Confounding effects of health status. Psychosom. Med. 66(6), 823–830 (2004)

PubMed  Article  Google Scholar 

J.P. Bilezikian et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561–3569 (2014)

CAS  PubMed  PubMed Central  Article  Google Scholar 

J.P. Bilezikian, A.A. Khan, J.T. Potts Jr., Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J. Clin. Endocrinol. Metab. 94(2), 335–339 (2009)

CAS  PubMed  PubMed Central  Article  Google Scholar 

A. Khan et al. Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery. Eur. J. Endocrinol. 172(5), 527–535 (2015)

CAS  PubMed  PubMed Central  Article  Google Scholar 

N. Yu et al. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin. Endocrinol. (Oxf.) 71(4), 485–493 (2009)

Article  Google Scholar 

B. Cho, C.M. Lee, Current situation of national health screening systems in Korea. J. Korean Med. Assoc. 54(7), 666–669 (2011)

Article  Google Scholar 

M.W. Yeh et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 98(3), 1122–1129 (2013). p

CAS  PubMed  PubMed Central  Article  Google Scholar 

M.S. Lui et al. Stones left unturned: Missed opportunities to diagnose primary hyperparathyroidism in patients with nephrolithiasis. Surgery 171(1), 23–28 (2022). p

PubMed  Article  Google Scholar 

C. Cipriani et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J. Clin. Endocrinol. Metab. 100(4), 1309–1315 (2015)

CAS  PubMed  PubMed Central  Article  Google Scholar 

S.H. Obligado, D.S. Goldfarb, The association of nephrolithiasis with hypertension and obesity: a review. Am. J. Hypertens. 21(3), 257–264 (2008)

CAS  PubMed  Article  Google Scholar 

E.N. Taylor, M.J. Stampfer, G.C. Curhan, Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 68(3), 1230–1235 (2005)

PubMed  Article  Google Scholar 

H. Aydin et al. Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis. Urol. Res 39(6), 451–458 (2011)

CAS  PubMed  Article  Google Scholar 

M.L. Stoller et al. The primary stone event: a new hypothesis involving a vascular etiology. J. Urol. 171(5), 1920–1924 (2004)

PubMed  Article  Google Scholar 

R.T. Alexander et al. Kidney stones and cardiovascular events: a cohort study. Clin. J. Am. Soc. Nephrol. 9(3), 506–512 (2014)

PubMed  Article  Google Scholar 

G. Agarwal et al. Cardiovascular dysfunction in symptomatic primary hyperparathyroidism and its reversal after curative parathyroidectomy: results of a prospective case control study. Surgery, 154(6), 1394–1403 (2013)

Article  Google Scholar 

R.P. Espiritu et al. Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J. Clin. Endocrinol. Metab. 96(11), E1737–E1745 (2011)

CAS  PubMed  Article  Google Scholar 

M. Daskalopoulou et al. Depression as a risk factor for the initial presentation of twelve cardiac, cerebrovascular, and peripheral arterial diseases: Data Linkage Study of 1.9 Million Women and Men. PLoS One 11(4), e0153838 (2016)

PubMed  PubMed Central  Article  Google Scholar 

H. Cai et al. Major depression and small vessel stroke: A Mendelian randomization analysis. J. Neurol. 266(11), 2859–2866 (2019). p

CAS  PubMed  Article  Google Scholar 

R. Rosmond, P. Björntorp, The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J. Intern. Med. 247(2), 188–197 (2000)

CAS  PubMed  Article  Google Scholar 

B.R. Walker, Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 157(5), 545–559 (2007)

CAS  PubMed  Article  Google Scholar 

J. Wild et al. A prospective study of pre-trauma risk factors for post-traumatic stress disorder and depression. Psychol. Med 46(12), 2571–2582 (2016)

CAS  PubMed  PubMed Central  Article  Google Scholar 

J.E. Dimsdale, Psychological stress and cardiovascular disease. J. Am. Coll. Cardiol. 51(13), 1237–1246 (2008)

PubMed  PubMed Central  Article  Google Scholar 

M. Karakose et al. The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism. Endocrine 55(1), 283–288 (2017)

CAS  PubMed  Article  Google Scholar 

S. Kumar et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 40(1), 47–53 (1994)

CAS  Article  Google Scholar 

N. Verheyen et al. Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial. Clin. Chem. Lab. Med. (CCLM) 55(7), 1034–1042 (2017)

CAS  Article  Google Scholar 

T. Weber et al. Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg. 148(2), 109–115 (2013)

PubMed  Article  Google Scholar 

A. Koman et al. Neuropsychiatric Comorbidity in Primary Hyperparathyroidism Before and After Parathyroidectomy: A Population Study. World J. Surg. 46(6), 1420–1430 (2022)

CAS  PubMed  PubMed Central  Article  Google Scholar 

S. Ljunghall et al. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur. J. Clin. Invest 13(5), 373–377 (1983)

CAS  PubMed  Article  Google Scholar 

S. Tournis et al. Cardiovascular risk in patients with primary hyperparathyroidism. Curr. Pharm. Des. 26(43), 5628–5636 (2020)

CAS  PubMed  Article  Google Scholar 

J.R. Petrie, T.J. Guzik, R.M. Touyz, Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can. J. Cardiol. 34(5), 575–584 (2018)

PubMed  Article  Google Scholar 

A. Juutilainen et al. Type 2 diabetes as a “coronary heart disease equivalent”: an 18-year prospective population-based study in Finnish subjects. Diabetes Care 28(12), 2901–2907 (2005)

PubMed  Article  Google Scholar 

E. Rapsomaniki et al. Blood pressure and incidence of twelve cardiovascular